Correlation Between Esperion Therapeutics and Collegium Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and Collegium Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and Collegium Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and Collegium Pharmaceutical, you can compare the effects of market volatilities on Esperion Therapeutics and Collegium Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of Collegium Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and Collegium Pharmaceutical.
Diversification Opportunities for Esperion Therapeutics and Collegium Pharmaceutical
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Esperion and Collegium is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and Collegium Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Collegium Pharmaceutical and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with Collegium Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Collegium Pharmaceutical has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and Collegium Pharmaceutical go up and down completely randomly.
Pair Corralation between Esperion Therapeutics and Collegium Pharmaceutical
Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 2.2 times more return on investment than Collegium Pharmaceutical. However, Esperion Therapeutics is 2.2 times more volatile than Collegium Pharmaceutical. It trades about 0.31 of its potential returns per unit of risk. Collegium Pharmaceutical is currently generating about -0.17 per unit of risk. If you would invest 203.00 in Esperion Therapeutics on September 2, 2024 and sell it today you would earn a total of 77.00 from holding Esperion Therapeutics or generate 37.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Esperion Therapeutics vs. Collegium Pharmaceutical
Performance |
| Timeline |
| Esperion Therapeutics |
| Collegium Pharmaceutical |
Esperion Therapeutics and Collegium Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Esperion Therapeutics and Collegium Pharmaceutical
The main advantage of trading using opposite Esperion Therapeutics and Collegium Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, Collegium Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collegium Pharmaceutical will offset losses from the drop in Collegium Pharmaceutical's long position.| Esperion Therapeutics vs. Elanco Animal Health | Esperion Therapeutics vs. SIGA Technologies | Esperion Therapeutics vs. Catalent | Esperion Therapeutics vs. ANI Pharmaceuticals |
| Collegium Pharmaceutical vs. Phibro Animal Health | Collegium Pharmaceutical vs. ANI Pharmaceuticals | Collegium Pharmaceutical vs. Procaps Group SA | Collegium Pharmaceutical vs. Amphastar P |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |